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Gene for susceptibility to diabetic nephropathy in type 2 diabe- thy, the diabetes-related loss of kidney function, is one
tes maps to 18q22.3-23. of the major complications of diabetes. Diabetic nephrop-
Background. Diabetic nephropathy is the major cause of athy is characterized by persistent proteinuria, that is,end-stage renal failure in patients with diabetes mellitus types 1
the presence of protein in the urine. The incidence ofand 2. Epidemiological studies have suggested a genetic suscepti-
this complication peaks during the second decade ofbility to diabetic nephropathy. The aim of this study was to localize
the gene(s) responsible for susceptibility to diabetic nephropathy. diabetes mellitus type 1 and declines thereafter [2, 3].
Methods. A genetic linkage analysis was performed in 18 Diabetic nephropathy is the major cause of end-stage
large Turkish families with type 2 diabetes mellitus and diabetic
renal failure in the Western world.nephropathy. The result was checked in 101 affected sibling pairs
Despite often poorly controlled blood glucose concen-of Pima Indians.
Results. A highly significant LOD score of 6.1 on chromo- trations, a major subgroup of patients with type 1 [2, 4–6]
some 18q22.3-23 between the markers D18S469 and D18S58 or type 2 diabetes mellitus never develops nephropathy
was obtained in multipoint analysis. There was no indication [6, 7]. This observation and the clustering of diabeticfor locus heterogeneity. In Pima Indians, linkage to the markers
nephropathy in families with type 1 [8, 9] and type 2D18S469 and D18S58 was confirmed (P  0.033), using the
[10, 11] diabetes suggest that only a subset of diabeticaffected sib-pair method. The genetic model that fit best was
a dominant mode of inheritance with an almost complete pene- patients is susceptible to the development of diabetic
tration in the Turkish population. nephropathy. Besides a genetic susceptibility to diabetes
Conclusions. There is strong evidence for the localization
mellitus there may be one or more other (modifier) genesof a gene responsible for diabetic nephropathy in Turkish type 2
for the susceptibility to diabetic nephropathy. Seaquistdiabetes mellitus patients. This locus maps to chromosome
18q22.3-23, between D18S43 and D18S50, an interval of 8.5 cM. et al found that the prevalence of nephropathy was 83%
in diabetic siblings of patients who already had devel-
oped a diabetic nephropathy, whereas the prevalence
Diabetes mellitus type 2 usually begins in mid life or was only 17% in diabetic siblings of diabetic patients
beyond, but also may occur in young individuals. Ac- without proteinuria [8]. Quinn et al and Krolewski con-
cording to the International Diabetes Federation type 2 firmed that the risk in siblings varied according to the
accounts for 90% of all diabetes, with a prevalence of proband’s status and hypothesized the existence of a
approximately 4%. The prevalence of type 2 diabetes in major gene causing nephropathy in patients with diabe-
the Turkish population is 6.9% [1]. Diabetic nephropa- tes. Although they could not reject a recessive mode of
inheritance, both studies postulated that diabetic ne-
phropathy is inherited as a dominant trait [9, 12].
Key words: genetics, diabetes mellitus, linkage analysis, end-stage renal
The prevalence of diabetic nephropathy varies amongdisease, insulin dependency, proteinuria, type 2 diabetes in Turkey,
Pima Indian study. different ethnic groups. The highest prevalence has been
found in Pima Indians with a cumulative incidence of
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population the risk of developing nephropathy is compa- buminuria (non-affected disease status) when they ful-
filled all of the following criteria: a duration of diabetesrable to that of the general Caucasian population (unpub-
lished observation). mellitus of at least 15 years, a urine albumin excretion
30 mg/24 h, an albumin-to-creatinine ratio of20 mg/g,Besides diabetic nephropathy, there are two other rel-
evant long-term complications of diabetes mellitus, namely, a negative reading of albumin and protein (in reagent
strips) in at least two of three morning urine samples.retinopathy and neuropathy. The susceptibility gene(s)
for diabetic nephropathy are likely to differ from the All other patients, including patients with microalbu-
minuria, patients treated with angiotensin converting en-modifier gene(s) for retinopathy and neuropathy [12].
For diabetic nephropathy a variety of candidate genes zyme (ACE) inhibitors and patients treated with angio-
tensin II receptor antagonists (AIIAs) were given anhave been studied and subsequently excluded [12].
The aim of the present study was to localize the gene(s) unknown disease status. Family members without diabe-
tes mellitus also were classified as status unknown, sinceresponsible for susceptibility to diabetic nephropathy. We
performed a linkage analysis in large Turkish families the absence of diabetes prohibited any clinical investiga-
tion on their susceptibility to nephropathy.with type 2 diabetes and confirmed our results in a sec-
ond, unrelated cohort of Pima Indians. We demonstrated
Patient selectionthe feasibility of the genetic mapping of a modifier gene
by linkage analysis. The study on the Turkish families was approved by
the ethics committees of the Medical Faculty of the Ege
University in Izmir (Turkey), and of the Faculty for
METHODS
Clinical Science at Mannheim of the University of Hei-
Diagnostic criteria for the Turkish patients delberg. Subjects gave written informed consent. The
first author screened a total of 3800 medical files of pa-The probands and their relatives were examined clini-
cally by an endocrinologist (I.V.) and an ophthalmologist tients with diabetes mellitus at the Ege University Hospi-
tal; 15% of these index patients were selected for an(I.A.), and the examinations took place in the homes of
the study participants. A home glucometer was used to interview. They were recruited from a large area (the
western region of Turkey) containing millions of inhabi-determine glucose levels. For further examinations fasting
plasma glucose was measured by the hexokinase method. tants. In addition, individuals from this region were in-
vited to participate by radio and local newspapers. OnlyNormoglycemia was defined as a fasting plasma glucose
126 mg/dL in at least two measurements. Serum and families—23 in total—with at least three available dia-
betic adult sibs, each with type 2 diabetes mellitus andurinary creatinine concentrations were measured by an
autoanalyzer. Urine albumin concentrations were mea- a duration of diabetes of at least 15 years, were selected
for this study. Of these 23 families five had to be ex-sured by an immunological method (MAU, Tina-quant;
Roche Diagnostics, Mannheim, Germany). cluded, since none of the patients had diabetic nephropa-
thy. Thus, 18 families (368 subjects) were selected forPatients with diabetes mellitus were classified as hav-
ing diabetes-related proteinuria (affected status) when linkage analysis (Fig. 1). These families are not known to
be related. DNA samples were obtained from 125 subjects:all of the following criteria were fulfilled: the presence
of urine albumin excretion 300 mg/24 h, an albumin- 61 normoalbuminuric diabetes patients; 28 subjects clas-
sified as proteinuric; and 36 individuals with an unknownto-creatinine ratio of300 mg/g, a positive protein read-
ing (at least 30 mg/dL), an albumin reading of at least status (Table 1). In most families, there was a combina-
tion of patients with early onset and late onset diabetes100 mg/L (measured in reagent strip, Micral Test II)
in the morning urine in at least two of three samples mellitus type 2. One relative was diagnosed with diabetes
type 1 and consequently was excluded from the study.(subjects with end-stage renal disease were considered
to have diabetic nephropathy, even if there were no mea-
Linkage analysis in Turkish familiessurements of protein and albumin in urine available), the
presence of diabetic retinopathy, the absence of urinary DNA was extracted from ethylenediaminetetraacetic
acid (EDTA)-blood by a standard salting out procedure.tract infections, the absence of kidney diseases other
than diabetic nephropathy, and absence of heart failure We performed a partial genome scan by typing loci se-
lected from the Genethon linkage map [16]. The markersor fever. The presence of retinopathy (diagnosed ac-
cording to a modification of the Airlie House Classifica- define a 10 cM resolution map. Distances were calcu-
lated according to The Genetic Location Database (LDB)tion Scheme [15]) was regarded as a necessary prerequi-
site, since we could not perform a renal biopsy and had (http://cedar.genetics.soton.ac.uk/public_html/ldb.html) and
Primer sequences were obtained from The Genome Data-to exclude proteinuria due to secondary causes, that is,
not related to diabetes (in this study, there were no base (http://gdbwww.gdb.org/). The samples were ana-
lyzed on an ALF-Express Sequencer (Amersham Phar-patients who had proteinuria without retinopathy).
Individuals were classified as patients with normoal- macia Biotech GmbH, Freiburg, Germany). Simulation
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Fig. 1. Pedigrees of the 18 Turkish families. The half closed symbols indicate patients with type 2 diabetes mellitus (DM) and diabetic nephropathy
(DN). The quarter closed symbols indicate patients with type 2 DM since at least 15 years, but no DN. The crossed symbols indicate patients with
type 2 DM since at least 15 years and microalbuminuria. Symbols with question mark indicate patients with no information or with type 2 DM,
but without information about DN. Symbols with a diagonal line indicate deceased individuals.
analysis was performed by using SLINK [17] (http://linkage. scored consistently across families and allele frequencies
were calculated by allele counting over all individualsrockefeller.edu/ott/SLINK.htm). We simulated polymor-
phic markers with four alleles, at inter-marker distances using the DOWNFREQ (ftp://linkage.cpmc.columbia.edu/
software/analyze) program. GENEHUNTER-PLUS [18]of 10 cM. The following disease parameters were used:
gene frequency 0.5, a phenocopy rate of 0.05, and a re- was used for the linkage and heterogeneity analysis. Non-
parametric NPL scores were calculated by GENE-duced penetration for the proteinuria (0.95). Alleles were
Vardarli et al: Modifier gene locus for diabetic nephropathy 2179
Fig. 1. (Continued)
HUNTER-PLUS [18] (default NPL scoring settings) and of diabetes D, which is the duration at onset of nephropa-
thy for affected persons and duration at the last examina-ASM (linear analysis).
tion for unaffected persons. The cumulative incidence
Pima Indians was calculated from the longitudinal epidemiologic study
in the Pimas. This duration-adjusted nephropathy scoreThe study on Pima Indians was approved by the insti-
tutional review board of The National Institute of Diabe- resulted in a quantitative trait that allowed for the analy-
sis of unaffected individuals and that improved the powertes and Digestive and Kidney Diseases and the Tribal
Council of the Gila River Indian Community, and sub- to detect susceptibility loci [19]. Linkage with this quanti-
tative trait was assessed with the Haseman-Elston regres-jects gave informed consent. A total of 1338 Pima Indians
taking part in a longitudinal study of type 2 diabetes and sion method. The allele frequencies were determined by
allele counting among all participants, as described ingenotyped previously in a genomic scan for diabetes [19]
were genotyped for chromosome 18 markers. Polymer- Hanson et al [21]. Distributions of IBD for all chromo-
somal locations (increments of 1 cM) were generatedase chain reaction (PCR) fragments were electropho-
resed on an ABI377 (Perkin Elmer ABI, Norwalk, CT, from all 19 markers on chromosome 18 for multipoint
analyses, using the method of Fulker, Cherny and Car-USA). Among the subjects with diabetes, nephropathy
was defined as a protein-to-creatinine ratio of at least don [22].
0.5 observed during the longitudinal study (excluding
those who had developed proteinuria prior to the onset
RESULTS
of diabetes). By this definition, there were 58 sibships
Family recruitment and simulation analysis inwhere there was at least one affected sibling pair; in total
Turkish familiesthere were 101 affected sibling pairs [20]. Non-parametric
methods were used to assess linkage. We calculated a dura- Eighteen Turkish families with a total of 368 subjects
were examined. DNA was obtained from 125 subjects.tion-adjusted nephropathy score as Y-CID, where Y is an
indicator variable for affection status and CID is the cu- As our aim was to map a modifier gene responsible for
diabetic nephropathy and not to investigate the cause ofmulative incidence of nephropathy at a specific duration
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diabetes mellitus itself, we had to extract the relevant
clinical information. Family members without diabetes
were defined as “status unknown” individuals, individu-
als with a duration of both diabetes and normoalbuminu-
ria of at least 15 years as “unaffected,” and individuals
with diabetes and proteinuria as “affected” (Methods
section). Our simulation studies demonstrated that the
power to detect linkage was satisfactory with a LOD
(log odds for linkage) score1 in 86% and a LOD score
3 in 36% of the replicates for the dominant model. A
subset of eleven nuclear families were observed to ac-
count for a power of 69% to detect a LOD score 1.0.
We decided to use these 11 nuclear families (75 DNA
samples) for our initial genome scan.
Genotyping and linkage analysis
In the Turkish families linkage analysis was performed
using microsatellite markers from 12 human chromo-
somes including regions for which evidence for linkage
for diabetic nephropathy had already been suggested
(3q, 7q, 9q and 20q) [20, 23]. We tested two models: a
recessive and a dominant mode of inheritance.
In the 11 nuclear families the linkage analysis on chro-
mosomes 12, 15, 16 and 20 and partial analysis of chromo-
somes 1p and 1 q (D1S2826 D1S2647, D1S213, D1S459),
3q (D3S1744, D3S1308, D3S1279, D3S1763, D3S3053),
9q (D9S283, D9S287), 11 (D11S922, D11S902) and 19
(D19S209, D19S221, D19S191) showed no evidence for
linkage for diabetic nephropathy in two-point analysis
and multipoint analysis. Linkage for chromosomes 7 and
17 could not be substantiated by multipoint analysis (Ta-
ble 2). The 11 nuclear families revealed a significant
pair-wise LOD score when the markers were typed on
chromosome 18q22.3-23 using the autosomal dominant
model (maximum LOD score 3.5; P 0.0001). On chro-
mosome 18 the LOD score remained significant and in-
creased to 6.1 when all 18 families and all markers in
a multipoint analysis were included (Fig. 2). The non-
parametric analysis showed a maximum score (P 
0.009) at approximately the same position although with
less significance. The maximum LOD score for linkage
of the trait locus, denoted DIANPH, was found between
the markers D18S469 and D18S58. By using the “maxi-
mum LOD – 1” method [24], we constructed a support
interval with an asymptotic confidence greater than 95%.
The DIANPH support interval was flanked by the mark-
ers D18S43 (proximally) and D18S50 (distally). The dis-
tance between these flanking markers was 8.5 cM (ap-
proximately 2.9 Mb). The maximum LOD score for the
autosomal recessive model was 2.3 in multipoint analysis.
Locus heterogeneity was tested by using the admixture
test. Although some of the families showed no positive
LOD score in the 18q22.3-23 region (Table 3), the maxi-
mum LOD score was found for   1 (where  is the
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proportion of linked families). Therefore, there was no
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Table 2. Results of the partial genome scan
Dominant model LODmax Recessive model LODmax
Non-parametric linkage analysisb
LOD equivalent LOD equivalent of
Chromosome Markers/N Multipoint Pair-wise Multipoint Pair-wise of Zlr max NPL score max
1 4 0.00 0.00 0.00 0.00 0.00 0.00
3 5 0.00 0.00 0.00 0.00 0.71 0.45
7 17 1.30a 1.82a 1.65a 1.70a 0.56 0.22
9 2 0.00 0.00 0.00 0.00 0.05 0.03
11 2 0.00 0.00 0.00 0.00 0.54 0.09
12 16 0.73a 0.79a 0.71a 0.40a 0.39 0.13
15 10 0.00 0.00 0.00 0.00 0.32 0.10
16 12 0.00 0.00 0.00 0.07 0.60 0.26
17 14 0.62a 1.38a 1.07a 1.53a 0.59 0.25
18 (nuclear fam.) 21 4.71 3.45 1.91 2.42 1.39 1.19
18 (all families) 21 6.14 3.65 2.26 0.55 1.72 1.33
19 3 0.00 0.13 0.00 0.00 0.32 0.08
20 12 0.74a 0.71a 0.00 0.32a 0.19 0.06
a Maximum LOD score was found on chromosome 7 between the markers D7S669 and D7S657; for chromosome 12 the multipoint max. LOD score was found
between the markers D12S99 and D12S364, and for the pair-wise analysis near to D12S310 for the dominant model and near to D12S326 for the recessive model;
for chromosome 17 the multipoint max LOD score was found between the markers D17S945 and D17S799, and for the pair-wise analysis the maximum LOD score
was found near to the marker D17S795; for chromosome 20 the multipoint and pair-wise max. LOD score was found between the markers D20S473 and D20S95.
b Calculated according to Kong and Cox [18]
Fig. 2. Cumulative multipoint LOD scores
on chromosome 18 in the 18 extended Turkish
families. Symbols are: (solid line) dominant
inheritance; (dotted line) recessive inheritance;
(dashed dot lines) LOD equivalent of Zlr (cal-
culated according to Kong and Cox [18]). Also
shown are the cumulative multipoint LOD
scores for the dominant model in the 11 nu-
clear families (dashed line), prior to extension.
indication for locus heterogeneity within the Turkish was redone with all diabetic patients redefined as affected.
This resulted in smaller LOD scores both for the dominantfamilies we investigated. The results were not sensitive
to the disease allele frequency, since results obtained (LOD 0.2) and the recessive model (LOD 0.0).
In the present study patients with microalbuminuriafor more extreme frequencies (10% and 90%) were not
below the 3.0 LOD score threshold (the obtained LOD were not classified as affected but as “status unknown.”
However, when microalbuminuric patients were in-scores were 4.3 and 4.8, respectively). A more detailed
investigation of the pedigrees and the marker data re- cluded as “affected” [arbitrarily with a reduced penetra-
tion (80%) and a 20% phenocopy rate], the results ofvealed that the penetration and phenocopy parameter
values were well chosen. In the 18 Turkish families the the study were not greatly changed (for dominant mode
of inheritance, maximum multipoint LOD score was 6.6real phenocopy rate approximated 0.0000% and the pen-
etration was approximately 98%. To eliminate the possi- instead of 6.1; maximum pair-wise LOD score 3.25; for
recessive mode of inheritance the maximum multipointbility that the mapped gene was simply a diabetes predis-
posing gene (and not a nephropathy gene), the analysis LOD score was 2.2).
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Table 3. Multipoint LOD scores (Z) and simulated LOD scores in By convention the genome-wide significance level is 5%.
18 extended Turkish families
The translation into critical LOD scores depends on the
Maximum number of performed tests, in our case determined by
Z at simulated the number of markers and the two genetic models.Family number DIANPH Zmax at 18q LOD score
According to recommendations of Hodge, increasing the
1 0.99 0.99 1.29
LOD score threshold to 3.3 ensures genome-wide sig-2a 0.81 0.81 0.90
2b 0.53 0.58 0.67 nificance at least at the 5% level (P  0.05) [25]. The
3 0.83 0.95 0.92 analysis of the second cohort of Pima Indians represents
4 0.25 0.47 0.61
a candidate analysis because of the previous significant5 0.25 0.25 0.48
6 0.23 0.44 0.98 result obtained in the group of Turkish patients. There-
7 0.01 0.10 0.58 fore, the result is confirmed if linkage to the candidate
8 0.17 0.54 0.53
locus is significant at the 5% level, as is the case in our9 0.34 0.97 1.21
10 0.12 0.25 0.25 study.
11 0.32 0.55 0.54 In our study, patients with microalbuminuria were not
12 0.04 0.04 0.03
classified as affected but as “status unknown.” While13 0.73 0.73 1.25
14 0.10 0.17 0.16 patients with microalbuminuria may or may not develop
15 0.14 0.53 0.52 diabetic nephropathy, we felt that this was the best op-
16 0.13 0.00 0.23
tion. In the present study when microalbuminuric pa-17 0.11 0.11 0.16
18 0.37 0.37 0.50 tients were included as “affected” the results of the study
Total 6.14 7.08a did not change greatly.
Our findings suggest that this is a major locus forFamily 2 consists of two parts, connected by a non-affected individual. The
branches (2a) and (2b) were calculated separately to allow for possible intrafami- diabetic nephropathy in the Turkish families. Since link-
lial locus heterogeneity.
age to 18q22.3-23 was confirmed in Pima Indians, wea Maximum LOD score in 1000 replicates; in some families the maximum
simulated LOD score was lower than the obtained LOD score at 18q, since not conclude that DIANPH mutations might be of relevance
more than four alleles were simulated
in different ethnic groups. A previous affected sib-pair
linkage study in this same group of Pima Indians found
some evidence for linkage (LOD1.2) to chromosomes
3, 7, and 20, but did not find strong evidence for linkageStudy in Pima Indians
to this region of chromosome 18 (LOD 0.3). Genotyp-All individuals included in the recent linkage study
ing of additional markers in the present study, as welldescribed by Hanson et al [21] were genotyped at mark-
as the addition of three more affected pairs, increaseders D18S469 and D18S58 in addition to the 17 chromo-
the LOD score modestly to 0.7. Segregation analyses ofsome 18 markers genotyped in the original genomic scan.
diabetic nephropathy in Pimas are consistent with a ma-Two nonparametric methods were employed to analyze
jor genetic influence on prevalence of diabetes [26]. Link-linkage with nephropathy among diabetic sibling pairs:
age analyses using the parameters of the segregationan affected-sib-pair method and a Haseman-Elston anal-
model also did not show linkage to this region of chromo-ysis of duration-adjusted nephropathy scores, which al-
some 18, but did give a LOD of 1.5 about 60 cM centro-lowed for the analysis of unaffected individuals. The re-
meric [27]. Thus, the locus that is inferred in the Turkishsults in affected sib-pairs of Pima Indians confirmed
families in the present study does not appear to be thelinkage of DIANPH to the markers D18S469 and D18S58.
major nephropathy susceptibility gene in the Pimas, butThe maximum multipoint LOD score was 0.73 (P 
may still have a significant effect. Therefore, we cannot0.033). For the duration-adjusted nephropathy score, the
completely exclude genetic heterogeneity. The almostmaximum multipoint LOD score was 0.55 (P  0.057).
complete penetrance obtained in the Turkish families
might be influenced by poor glycemic control and might
DISCUSSION therefore not be comparable to the penetration in other
Caucasian populations.The aim of our study was to localize the gene(s) caus-
ing nephropathy in patients with diabetes mellitus type Essential to our research strategy was the precise clini-
cal definition of the trait, diabetic nephropathy. Protein-2. Our data provide evidence for a major locus on chro-
mosome 18. The significance of the multipoint LOD uria also can occur due to non-diabetic causes. Stephen-
son et al have shown a positive correlation between thescore of 6.1 is beyond any doubt, even after adjustment
for multiple testing. Apart from the model-free analysis, degree of retinopathy and level of albuminuria [28]. Mac-
roalbuminuria without retinopathy is rare in patientstwo genetic models were tested. Since the LOD score
of the recessive model was only 2.3, this model is not with type 1 diabetes mellitus and presumably also in
patients with type 2 diabetes mellitus [28]. To excludesupported. The results fit best to the hypothesis that
diabetic nephropathy is inherited as a dominant trait. subjects with elevated urinary albumin excretion due to
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natural history of nephropathy in type I diabetes. Am J Med 78:785–non-diabetic reasons, only subjects with retinopathy in
794, 1985
addition to the other criteria were classified as protein- 5. Krolewski AS, Warram JH, Rand LI, Kahn CR: Epidemiologic
uria due to diabetic nephropathy. approach to the epidemiology of diabetes mellitus and its complica-
tions. N Engl J Med 317:1390–1398, 1987The region flanked by the markers D18S43 and D18S50
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